Financing, Equity Capital Markets

Gossamer Bio

05/20
|
$200.0 Million
Piper Sandler served as bookrunner for Gossamer Bio, Inc. on a convertible offering
Sub-Type
Convertible Offering
Sub-Sector
Biopharma